Related Experiment Video
Updated: Apr 30, 2026

09:59
A Magnetic Resonance Imaging Protocol for Stroke Onset Time Estimation in Permanent Cerebral Ischemia
Published on: September 16, 2017
14.2K
Stroke-Aware CycleGAN: Improving Low-Field MRI Image Quality for Accurate Stroke Assessment
IEEE Transactions on Medical Imaging
|September 3, 2025
Summary
A new deep learning model, SA-CycleGAN, enhances low-field MRI images for stroke diagnosis. It improves image clarity and lesion quantification, offering a cost-effective solution for better stroke detection.
Area of Science:
- Medical Imaging
- Artificial Intelligence
Background:
- Low-field portable MRI (pMRI) offers accessible imaging but produces low-resolution images, hindering stroke diagnosis.
- Accurate lesion quantification is crucial for effective stroke management and treatment planning.
Purpose of the Study:
- To develop a 3D deep learning model (SA-CycleGAN) to enhance low-field MRI image quality for stroke diagnosis.
- To improve the diagnostic accuracy and lesion quantification capabilities of pMRI devices.
Main Methods:
- Proposed SA-CycleGAN, a 3D deep learning model based on CycleGAN, incorporating stroke lesion priors via spatial feature transformation.
- Integrated gradient difference losses to mitigate over-smoothing in synthesized images.
- Utilized a dataset of 101 paired high-field and low-field diffusion-weighted imaging (DWI) scans.
Main Results:
- SA-CycleGAN generated images with significantly higher quality and clarity compared to original low-field DWI.
- Lesion volume quantification showed a strong correlation (R=0.852) between SA-CycleGAN generated images and high-field images, outperforming low-field images (R=0.462).
- Mean absolute difference in lesion volumes was significantly smaller for SA-CycleGAN (1.73±2.03 mL) compared to low-field images (2.53±4.24 mL).
Conclusions:
- SA-CycleGAN effectively enhances low-field MRI images, improving visual clarity and consistency with high-field scans.
- The model offers a cost-effective method for improving stroke diagnosis efficiency and accuracy in clinical settings.
- SA-CycleGAN demonstrates potential for wider adoption of pMRI in routine stroke care.

